Could artificial intelligence be used to detect Parkinson’s disease?

Chinese tech firm Tencent (Shenzen, China), British healthcare technology company Medopad (London, UK) and Ray Chaudhuri (National Parkinson Foundation International Centre of Excellence at King's College London, UK) are working together to develop a new method for assessing motor function in patients with Parkinson’s disease. The collaborative enterprise utilizes artificial intelligence (AI) to improve the efficiency of the motor function assessment process. “Our partnership with Tencent comes from a shared vision to change the future of healthcare as we know it. In combining Medopad's medical expertise and Tencent's technical capabilities, we hope to provide the technology needed to support clinicians...